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Hepatic coma, also known as hepatic encephalopathy, is loss of consciousness as a result of 
liver failure. Hepatic coma represents the final stage of hepatic encephalopathy - grade IV, a 
progressive brain dysfunction due to accumulation of substances toxic to the brain. Hepatic 
coma can rapidly progress and may ultimately lead to death. Therefore,  early diagonosis of 
hepatic coma is consirerably crucial for patients‘ life. If not, patients with hepatic coma can 
die in few days. In this study, I have proposed to overview early diagnosis of hepatic 
encephalopathy by breath analysis using electronic noses which are regarded as rapid, 
inexpensive way of gas detection.  
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1.INTRODUCTION 
Hepatic coma is loss of consciousness as a result of liver failure. The brain is poisoned by 
toxic substances due to failure of  the liver functionality.  The toxic substances are generated 
after accumulation of some byproducts of metabolism in the blood.  
The severity of encephalopathy is subdivided into four grades. Grade I and II are subtle 
symptom of brain. In grade III, significant brain damage occurs. Hepatic coma represents the 
final grade - grade IV of the brain dysfunction that toxic substances are collected  in the brain. 
At this stage, the entire brain is damaged and the patient with hepatic failure becomes 
unconscious and is unable to respond to painful stimuli (hepatic coma).  Ultimately, it may 
cause death. [1] 
Studies have revealed that in patients with advanced stages of encephalopathy resulting froim 
chronic liver failure, ammonia, regarded as toxic substance, levels in the brain may rise more 
than twentyfold [2]. Blood tests show an increase in ammonia levels, which is a marker the 
degree of accumulation of toxins in the brain as well. 
For the essence of patients health, early diagnosis of hepatic coma is vital. If early 
intervention is not committed, hepatic encephalopathy can rapidly progress and  become an 
acute emergency condition regarded as coma causing death in a few days.  
Current methods of diagnosis of the hepatic coma such as computed tomography scans are 
time-consuming, expensive, and involve invasive confirmation. The needs of rapid and 
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inexpensive methods have led researchers to find new techniques on the hepatic coma 
symptoms.  
Electronic nose is a device formed by an array of sensors which is capable of highly sensitive 
for detecting and identifyig VOC‘s.  Various studies have been conducted to identify various 
diseases using electronic nose with common pattern recognition algorithms. This study 
suggested that an electronic nose would detect and identify hepatic encephalopathy at 
advanced grades on the basis of the complex smellprints of numerous VOC‘s in exhaled 
breath from patients with hepatic encephalopathy  
The breath of a healthy person gives a different pattern than that of a one with failure. This 
difference could be detected and classified by the electronic nose and an appropriate pattern 
classification algorithm such as Neural Network and SVM. The main objective of this paper is 
to suggest that it is possible to recognize individuals affected by advanced stage of hepatic 
encephalopathy called hepatic coma, analyzing the olfactory signal of their breath by the use 
of an electronic nose with an appropriate classification algorithm. 
 
2.VOC’s as a Biomarker of Certain Diseases 
Since 1971, it has been well known that hundreds of VOCs are present in the human breath 
[3], and that some of these compounds are biomarkers or indicators with certain diseases. 
Metabolic changes within hepatic failure can lead to changes in the production of different 
volatile organic compounds [4] which may be detected in the samples of exhaled breath.  
Over the last two decades, many studies on breath analysis by combined gas 
chromatography–mass spectroscopy (GC–MS) have been conducted that several hundreds of 
different compounds in human breath was found. They reported that some volatile compounds 
in the breath are associated with certain diseases. For example, in the breath of patients with 
liver cirrhosis mercaptans and aliphatic acids were identified[5] while in the breath of uremic 
patients dimethyl- and trimethylamine were found [6]. Similarly, ammonia, manganase and 
mercaptans quantity in the blood are accepted as biomarkers of hepatic coma or hepatic 
failure.  
 
In addition,  alkanes are present in the lung cancer and formaldehyde in the breast cancer; the 
presence of isoprene in human breath is correlated to blood cholesterol levels; and patients 
with Type 1 diabetes have excess acetone in their breath. [7] 
 
3.The VOCs in the patients with liver disease 
Dimethyl sulfide, acetone, 2-pentanone and 2-butanone are considerably high level in the 
breath of liver patients. These chemical compounds are the reason of bad smell of the breath. 
Sulfur containing compounds are produced by disfunctioned metabolism of sulfur containing 
amino acids in the transamination body system. Normally, the amount of these compounds in 
blood and alveolar breath are low. Dysfunction of liver increases the level of these 
compounds, which have a characteristic smell, like the smell of rotten cabbage.  
The increased levels of the ketones acetone, 2-pentanone and 2-butanone are regarded to be 
the result of hepatic insuline resistance, a common disorder in patients with hepatic steatosis 
and end stage liver disease. Insuline resistance leads to an increase of triglycerides and free 
fatty acids and ketones are formed during lipolysis. Moreover, in a study with rats, the 
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amounts of these compounds increase because of the inhibition of certain enzymes in the 
liver.[8] 
The correlation between a biomarker and a specific disease is often multi-fold. A breath 
compound can be a biomarker of about more than one disease or metabolic-disorder. And one 
particular disease or metabolic disorder can be identified by more than one chemical 
compounds. Table 1 shows correlation certain diseases and compounds. 
Table 1. 35 established biomarkers and their physiological symptoms.[7] 
Biomarkers  Metabolic Disorders / Diseases  
Acetone (OC(CH3)2)  
Lung cancer, diabetes, dietary fat losses, 
congestive heart failure, brain seizure  
Acetaldehyde (CH3CHO)  
Alcoholism, liver related diseases, lung 
cancer  
Ammonia (NH3)  Renal diseases, asthma  
Butane (C4H10)  Tumor marker in lung cancer  
Carbon monoxide (CO)  
Oxidative stress, respiratory infection, 
anaemias  
Carbon disulphide (CS2)  Schizophrenia, coronary, and artery diseases  
Carbon dioxide (CO2) (13C-Isotopes)  Oxidative stress  
Carbonyl sulfide (OCS)  Liver related diseases  
Ethane (C2H6)  
Vitamin E deficiency in children, lipid 
peroxidation, oxidative stress  
Ethanol (C2H5OH)  Production of gut bacteria  
Ethylene (C2H4)  
Lipid peroxidation, ultra violet radiation 
damage of skin  
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Hydrogen (H2)  
Indigestion in infants, intestinal upset, 
colonic fermentation  
H/D isotope  Body water  
Hydrogen peroxide (H2O2)  Asthma  
Hydrogen cyanide (HCN)  
Pseudomonas aeruginosa in children affected 
with cystic fibrosis  
8-Isoprostane  Oxidative stress  
Isoprene  Blood cholesterol  
Methane (CH4)  Intestinal problems, colonic fermentation  
Methanethiol (CH3SH)  Halitosis  
Methanol (CH3OH)  Nervous system disorder  
Methylated amines  Protein metabolism in body  
Methyl nitrate (CH3NO3)  Hyperglycemia in Type 1 diabetes  
Nitrogen monoxide (NO) 
Asthma, bronchiectasis, hypertension, 
rhinitis, lung diseases 
Nitrotyrosine (C9H10N2O5)  Asthma  
Oxygen (O2)  Respiration  
Pentane (C5H12)  
Peroxidation of lipids, liver diseases, 
schizophrenia, breast cancer, rheumatoid 
arthritis  
Pyridine (C5H5N)  Periodontal disease  
Sulfur compounds  Hepatic diseases and malordor, lung cancer  
Hydrocarbons (Toulene (C6H5CH3), 
Benzene (C6H6), Heptane (C7H16), 
Decane (C10H22), Styrene (C8H8), 
Octane (C8H18), Pentamethylheptane 
(C12H26))  
Lipid peroxidation, lung cancer, oxidative 








An electronic nose is an instrument which is composed of an array of electro chemical sensors 
with partial specificity and an appropriate pattern recognition system, is able to detect and 
identify simple or complex odors. 
Electronic noses have been mainly used for quality control applications in the food, beverage, 
and cosmetics industries, military, and medical applications. As an odor is presented to the 
electronic nose, certain sensors are sensitive to the odor; therefore they respond to certain 
volatile componds. This combination of varied responses from the array of sensors constitutes 
the characteristic of the particular applied odors. After presence of analyte the output of the 
odor sensors is extracted, amplified, filtered, and converted into digital form by transducion 
electronics.   
Compared to traditional analysis techniques, electronic noses have certain motivations. The 
main motivation for electronic noses is capable of inexpensive, rapid, real-time as well as 
portable and reproducible measurements of volatile compounds. 
However,  a universal electronic nose has not been built yet, which is capable of identifying 
or discriminating any gas sample type with high efficiency and for all possible applications. 
Because it is highly depends on the selectivity and sensitivity limitations of electronic nose 
sensor arrays for particular analyte gases. Therefore, electronic noses are not univerally 
utilized for every application of the gas samples. A proper electronic nose for a particular 
application should meet an evaluation of mecanism.  
 
5.The Biological Nose  
The human olfactory system comprises variety of chemical sensors, known as receptors, and 
automated pattern recognition incorporated into the olfactory bulb and olfactory cortex in the 
brain [9, 10]. A receptor type alone can not identify a specific odor. It is the set of receptors  
composed of pattern recognition that can detect and identify each odor. Fig.3 shows the main 
components and function of the human olfactory system and its sensory components. Once 
odor molecules are presented to the olfactory receptors stimulating an electro-chemical 
response that is transmitted through the crib form plate to the olfactory bulb and ultimately the 
olfactory cortex. 
The olfactory receptors (sensors), the olfactory bulb (signal pre-processing), and the olfactory 




Figure 3. Human Olfaction Sensing System [11] 
 
6.Sensor Technologies on Electronic Nose 
Metal Oxide Semiconductor (MOS) was the first developed sensor array, which detected 20 
odours [12].  By the technological development sensor arrays are created from six up to 32 
sensors with different materials, detecting thousands of smells. This equipment varies 
different types of sensors interacting with volatiles: Metal Oxide Semiconductor Field Effect 
Transistors (MOSFETs), Quartz Crystal Microbalances (QCMs), the Surface Acoustic Waves 
(SAWs), Conducting Organic Polymer Sensors (CPs), Intrinsically Conducting Polymers 
(ICPs) and optical fiber bundles . Modern electronic noses (e-noses) can be constructed with 
more than one type of sensor in them. [13] 
 
7.CONCLUSION 
Up to date, many papers on medical research using electronic nose have been studied. Neural 
network is the appropriate pattern recognition method for identifying patients with hepatic 
failure and healty individuals. As medical sensing samples are non linear, the most 
appropriate classificatiton method is neural which can train and test non linear medical 
samples in a short time with high accuracy compared to other algorithms.  
One of key factor for sensing odor is using the appropriate sensor. After a long time research, 
it is believed that polymer film coated sensors are more suitable for the medical diagnosis usin 
electronic noses.  
As a result electronic noses are prominent system as non invasive method of medical 
diagnosis. The studies have been shown that with appropriate sensor arrays and corresponding 
pattern recognition, electronic nose can be widely used for many diseases. Therefore, for early 
detection of hepatic coma, patients with hepatic failure can be efficiently analyzed by 
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The aim of the this study was to examine the effects of the diets based on Soybean Meal 
(40%) supplemented with exogenous enzymes on growth performance, feed utilization, 
apparent digestibility and reduce environment pollution waste output of  nitrogen and 
phosphorus in rainbow trout (Oncorhynchus mykiss) culture. Trout groups (initial weight 
87.00±1,5) method of random plots with 3 replications of 50 fish/pond with the ratio of 1050 
fish in the concrete ponds. Diets consisted of 25% fish meal (FM)  and 40% dehulled hexane 
extracted soybean meal (SBM) in control group (C0) and diet supplemented with protease 
enzyme (PRT; 2g/kg-1), diet supplemented with enzyme cocktail (MIX; cellulose, xylanase, 
endo-ß-1,3:1,4-glucanase; 2g/kg-1) and diet supplemented with pyhtase enzyme (PHY;  
2g/kg-1).  About of  growth performance were found while condition factor (1,21-1,23) were 
statistically similar (p>0.05), however specific growth rate, SGR, (1,118-1,340) and feed 
conversion ratio, FCR, (1,26-1,30) were obtained significantly different among groups 
(p<0,05). PRT and PHY groups significantly improved SGR and  FCR better than control 
group. In this study, showed the highest nitrogen apperent digestibility coefficient, ADC 
(85,49±1,98) in PRT group while, the poorest value obtained (72,82±0.01) C0 group 
